185 related articles for article (PubMed ID: 22865302)
1. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
[TBL] [Abstract][Full Text] [Related]
2. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
3. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
5. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
[TBL] [Abstract][Full Text] [Related]
6. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
[TBL] [Abstract][Full Text] [Related]
7. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
[TBL] [Abstract][Full Text] [Related]
8. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
Modugno F; Kip KE; Cochrane B; Kuller L; Klug TL; Rohan TE; Chlebowski RT; Lasser N; Stefanick ML
Int J Cancer; 2006 Mar; 118(5):1292-301. PubMed ID: 16161054
[TBL] [Abstract][Full Text] [Related]
9. Estrogen metabolites and the risk of breast cancer in older women.
Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
[TBL] [Abstract][Full Text] [Related]
10. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
[TBL] [Abstract][Full Text] [Related]
11. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
Barba M; Yang L; Schünemann HJ; Sperati F; Grioni S; Stranges S; Westerlind KC; Blandino G; Gallucci M; Lauria R; Malorni L; Muti P
J Exp Clin Cancer Res; 2009 Oct; 28(1):135. PubMed ID: 19814782
[TBL] [Abstract][Full Text] [Related]
12. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense
Green T; See J; Schauch M; Reil J; Glover M; Brix J; Gerry A; Li K; Newman M; Gahler RJ; Wood S
J Complement Integr Med; 2023 Mar; 20(1):199-206. PubMed ID: 36201753
[TBL] [Abstract][Full Text] [Related]
14. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
[TBL] [Abstract][Full Text] [Related]
15. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.
Smith AJ; Phipps WR; Thomas W; Schmitz KH; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):756-64. PubMed ID: 23652373
[TBL] [Abstract][Full Text] [Related]
16. Associations between aerobic fitness and estrogen metabolites in premenopausal women.
Campbell KL; Westerlind KC; Harber VJ; Friedenreich CM; Courneya KS
Med Sci Sports Exerc; 2005 Apr; 37(4):585-92. PubMed ID: 15809556
[TBL] [Abstract][Full Text] [Related]
17. Estrogen metabolism and breast cancer.
Kabat GC; O'Leary ES; Gammon MD; Sepkovic DW; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Bradlow HL
Epidemiology; 2006 Jan; 17(1):80-8. PubMed ID: 16357599
[TBL] [Abstract][Full Text] [Related]
18. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
Bentz AT; Schneider CM; Westerlind KC
Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
[TBL] [Abstract][Full Text] [Related]
19. Effect of energy deficiency on estrogen metabolism in premenopausal women.
Westerlind KC; Williams NI
Med Sci Sports Exerc; 2007 Jul; 39(7):1090-7. PubMed ID: 17596776
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial.
Mackey RH; Fanelli TJ; Modugno F; Cauley JA; McTigue KM; Brooks MM; Chlebowski RT; Manson JE; Klug TL; Kip KE; Curb JD; Kuller LH
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2022-32. PubMed ID: 22933427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
